Literature DB >> 17058098

Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease.

Boris Hügle1, Itziar Astigarraga, Jan-Inge Henter, Anna Porwit-MacDonald, Alfons Meindl, Volker Schuster.   

Abstract

X-linked lymphoproliferative disease is a rare T and NK cell immune deficiency which most frequently presents as fulminant infectious mononucleosis following infection with the Epstein-Barr virus (EBV). We report the case of a 4-year-old boy from a Spanish family presenting with severe infectious mononucleosis. In the course of the disease he developed hepatic failure, pancytopenia and neurologic impairment, leading to death after less than 2 months. The results of bone marrow biopsy and autopsy indicated a histological diagnosis of both high-grade B-cell lymphoma and virus-associated haemophagocytic syndrome, thereby confirming the simultaneous presence of two different manifestations of X-linked lymphoproliferative disease (XLP) in this patient. The family history revealed four close male relatives dying under similar circumstances, one of whom died following a vaccination against measles. Molecular genetic studies identified a novel mutation in the SH2D1A gene in several members of the family, establishing the diagnosis of XLP. Fatal EBV infection in male infants is highly indicative of XLP. Virus-associated haemophagocytic syndrome and B-cell lymphoma can occur concomitantly and may be difficult to distinguish due to their similar histological pictures.

Entities:  

Mesh:

Year:  2006        PMID: 17058098     DOI: 10.1007/s00431-006-0290-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.860


  23 in total

1.  HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society.

Authors:  J I Henter; M Aricò; R M Egeler; G Elinder; B E Favara; A H Filipovich; H Gadner; S Imashuku; G Janka-Schaub; D Komp; S Ladisch; D Webb
Journal:  Med Pediatr Oncol       Date:  1997-05

Review 2.  Molecular and immunological basis of X-linked lymphoproliferative disease.

Authors:  Sylvain Latour; André Veillette
Journal:  Immunol Rev       Date:  2003-04       Impact factor: 12.988

3.  Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

Authors:  J Sumegi; D Huang; A Lanyi; J D Davis; T A Seemayer; A Maeda; G Klein; M Seri; H Wakiguchi; D T Purtilo; T G Gross
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

4.  Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.

Authors:  A C Lankester; L F A Visser; N G Hartwig; R G M Bredius; H B Gaspar; M van der Burg; M J D van Tol; T G Gross; R M Egeler
Journal:  Bone Marrow Transplant       Date:  2005-07       Impact factor: 5.483

Review 5.  X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.

Authors:  V Schuster; H W Kreth
Journal:  Immunol Rev       Date:  2000-12       Impact factor: 12.988

6.  B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics.

Authors:  M Miyahara; M Sano; K Shibata; M Matsuzaki; K Ibaraki; Y Shimamoto; O Tokunaga
Journal:  Ann Hematol       Date:  2000-07       Impact factor: 3.673

7.  Clinicopathological findings of virus-associated hemophagocytic syndrome in bone marrow: association with Epstein-Barr virus and apoptosis.

Authors:  K Ohshima; K Shimazaki; M Sugihara; S Haraoka; J Suzumiya; M Kanda; C Kawasaki; M Kikuchi
Journal:  Pathol Int       Date:  1999-06       Impact factor: 2.534

8.  Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis.

Authors:  E Pracher; E R Panzer-Grümayer; A Zoubek; C Peters; H Gadner
Journal:  Bone Marrow Transplant       Date:  1994-05       Impact factor: 5.483

Review 9.  X-linked lymphoproliferative disease: twenty-five years after the discovery.

Authors:  T A Seemayer; T G Gross; R M Egeler; S J Pirruccello; J R Davis; C M Kelly; M Okano; A Lanyi; J Sumegi
Journal:  Pediatr Res       Date:  1995-10       Impact factor: 3.756

10.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

View more
  3 in total

1.  Common variable immune deficiency associated Hodgkin's lymphoma complicated with EBV-linked hemophagocytic lymphohistiocytosis: a case report.

Authors:  Umit Yavuz Malkan; Gursel Gunes; Tuncay Aslan; Sezgin Etgul; Seda Aydin; Yahya Buyukasik
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease.

Authors:  Y N'guyen; L Andreoletti; M Patey; C Lecoq-Lafon; P Cornillet; A Léon; R Jaussaud; C Fieschi; C Strady
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

3.  A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).

Authors:  Irbaz Bin Riaz; Warda Faridi; Mrinal M Patnaik; Roshini S Abraham
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.